Sonoma Pharmaceuticals (SNOA) Short term Debt: 2011-2012
Historic Short term Debt for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to $1.4 million.
- Sonoma Pharmaceuticals' Short term Debt rose 20.13% to $1.1 million in Q4 2012 from the same period last year, while for Dec 2012 it was $1.1 million, marking a year-over-year increase of 20.13%. This contributed to the annual value of $1.4 million for FY2012, which is 56.01% up from last year.
- As of FY2012, Sonoma Pharmaceuticals' Short term Debt stood at $1.4 million, which was up 56.01% from $907,000 recorded in FY2011.
- Over the past 5 years, Sonoma Pharmaceuticals' Short term Debt peaked at $1.4 million during FY2012, and registered a low of $907,000 during FY2011.
- Moreover, its 2-year median value for Short term Debt was $1.2 million (2011), whereas its average is $1.2 million.
- Data for Sonoma Pharmaceuticals' Short term Debt shows a peak YoY spiked of 56.01% (in 2012) over the last 5 years.
- Yearly analysis of 2 years shows Sonoma Pharmaceuticals' Short term Debt stood at $907,000 in 2011, then skyrocketed by 56.01% to $1.4 million in 2012.